>Kailash29792: /* Career */clean up

2021-06-29T15:00:53Z

Career: clean up

New page

{{short description|Indian scientist and businessman}}
{{Use dmy dates|date=January 2019}}
{{Use Indian English|date=January 2019}}
{{Infobox person
| name = Yusuf Hamied
| image = Hamied.jpg
| image_size =
| caption = Dr. Yusuf Hamied (left) receiving Padma Bhushan from the then President of India Dr APJ Abdul Kalam (right).
| birth_name =
| birth_date = {{Birth date and age|1936|07|25|df=yes}}
| birth_place = [[Wilno]], [[Wilno Voivodeship (1926–39)|Wilno Voivodeship]], [[Second Polish Republic|Poland]] (now [[Vilnius]], Lithuania)
| death_date =
| death_place =
| death_cause =
| nationality = Indian
| education = [[Christ's College, Cambridge]]
| occupation =
| known for =
| home_town =
| salary =
| networth = {{up}} [[US$]] 3.3 billion (May 2021)<ref name=Forbes>{{cite web|title=Yusuf Hamied|url=https://www.forbes.com/profile/yusuf-hamied/|website=[[Forbes]]|access-date=25 February 2018}}</ref>
| title = Chairman, [[Cipla]]
| term =
| predecessor =
| successor = M. K. Hamied
| boards =
| spouse = Farida
| children = none
| parents = [[Khwaja Abdul Hamied]], Luba Derczanska
| relatives =
| website =
| awards = [[Padma Bhushan]]
}}

'''Yusuf Khwaja Hamied''' (born 25 July 1936) is a Polish-born-Indian scientist, [[billionaire]] businessman and the chairman of [[Cipla]], a generic [[pharmaceuticals]] company founded by his father [[Khwaja Abdul Hamied]] in 1935.<ref>{{cite news|author=Sarah Boseley |url=https://www.theguardian.com/world/2003/feb/18/aids.sarahboseley13 |title=Yusuf Hamied, generic drugs boss | World news |newspaper=The Guardian |date= 2003-02-18|access-date=2010-09-01 | location=London}}</ref> He is also an elected fellow of the [[Indian National Science Academy]].<ref>{{cite web |title=Fellows Elected 2019 |url=http://insaindia.res.in/pdf/IndFellows2020.pdf |publisher=[[Indian National Science Academy]] |access-date=2 August 2019 |archive-url=https://web.archive.org/web/20190802215436/http://insaindia.res.in/pdf/IndFellows2020.pdf |archive-date=2 August 2019}}</ref>

==Early life==
Hamied was born in [[Vilnius]], then Poland, now Lithuania, and raised in [[Bombay]] (now [[Mumbai]]). His Indian Muslim father and [[Russophone]] Lithuanian Jewish mother, Luba Derczanska<ref>{{Cite web|url=https://qz.com/india/601490/how-a-muslim-jewish-romance-shaped-one-of-indias-biggest-pharma-firms/|title=How a Muslim-Jewish romance shaped one of India’s biggest pharma firms|first=Kenneth X.|last=Robbins|website=Quartz India}}</ref> met in pre-war Berlin, where they were university students. Hamied was educated at the [[Cathedral and John Connon School]] and [[St. Xavier's College, Mumbai]].{{citation needed|date=April 2015}} He went to England in 1954, and earned a BA in chemistry in 1957, followed by a PhD, from [[Christ's College, Cambridge]]. He uses his chemistry notebooks from Cambridge when he develops new syntheses of drugs.<ref name="NYT generic">{{cite news|url=https://www.nytimes.com/2000/12/01/world/selling-cheap-generic-drugs-india-s-copycats-irk-industry.html|title=Selling Cheap 'Generic' Drugs, India's Copycats Irk Industry|author=Donald G. McNeil Jr|newspaper=[[The New York Times]]|date=2000-12-01|access-date=2016-01-26}}</ref>

==Career==
Hamied is best known outside India for defying large Western [[pharmaceutical companies]] in order to provide [[generic drug|generic]] [[antiretroviral drug|AIDS drugs]] and treatments for other ailments primarily affecting people in poor countries.<ref>{{cite web|url=http://news.bbc.co.uk/2/hi/south_asia/3220619.stm |title= Indian drugs boss hails Aids deal |date=2003-10-29 |access-date=2016-09-07}}</ref> Hamied has led efforts to eradicate [[AIDS]] in the developing world and to give patients life-saving medicines regardless of their ability to pay,<ref>{{cite web|url=http://www.highbeam.com/doc/1G1-70724835.html |title=Interview of the week: Yusuf Hamied. - United Press International | HighBeam Research - FREE trial |publisher=Highbeam.com |date=2001-02-22 |access-date=2010-09-01}}{{dead link|date=February 2019|bot=medic}}{{cbignore|bot=medic}}</ref> and has been characterized as a modern-day [[Robin Hood]] figure<ref>{{cite web|url=http://archiviostorico.corriere.it/2003/giugno/25/Yusuf_Hamied_Robin_Hood_contro_co_0_030625169.shtml |title=Yusuf Hamied, un Robin Hood contro l' Aids "Così sconfiggerò l' Aids senza le multinazionali" |publisher=Archiviostorico.corriere.it |access-date=2016-01-26}}</ref><ref>{{cite news|url=https://www.theguardian.com/world/2010/jul/06/india-eu-drugs-trade-deal|title=India fears generic drugs for poor are endangered by proposed EU trade deal | location=London | work=The Guardian|first=Frédéric|last=Bobin|date=2010-07-06}}</ref><ref>{{cite web|url=http://legacy.laika.nl/html/ctg/cd-rom/assets/ima/fn1102078524203para0.swf |title=TransIP - Reserved domain |publisher=Legacy.laika.nl |access-date=2016-01-26}}</ref><ref>{{cite web|url=http://www.spiegel.de/international/spiegel/0,1518,125799,00.html |title=English Summaries - SPIEGEL ONLINE |publisher=Spiegel.de |date=2001-04-02 |access-date=2016-01-26}}</ref> as a result.

Hamied stated, "I don't want to make money off these diseases which cause the whole fabric of society to crumble".<ref>Hans Lofgren, The Politics of the Pharmaceutical Industry and Access to Medicine, 2012.</ref>

In September 2011, in a piece about how he was trying to radically lower costs of biotech drugs for cancer, [[diabetes]] and other [[noncommunicable diseases]], ''The New York Times'' wrote of Hamied:

<blockquote>
Dr. Yusuf K. Hamied, chairman of the Indian drug giant Cipla Ltd., electrified the global health community a decade ago when he said he could produce cocktails of AIDS medicines for $1 per day — a fraction of the price charged by branded pharmaceutical companies. That price has since fallen to 20 cents per day, and more than six million people in the developing world now receive treatment, up from little more than 2,000 in 2001.<ref>{{cite news|url=https://www.nytimes.com/2011/09/19/health/policy/19drug.html?tntemail1=y&_r=1&emc=tnt&pagewanted=all |title=China and India Making Inroads in Biotech Drugs | work=The New York Times | first=Gardiner |last=Harris |date=2011-09-18}}</ref>
</blockquote>

Hamied has also been influential in pioneering development of multi-drug combination pills (also known as [[fixed-dose combinations]], or FDCs), notably for [[HIV/AIDS]], [[tuberculosis]] (TB), [[asthma]] and other ailments chiefly affecting developing countries, as well as development of pediatric formulations of drugs, especially those benefiting children in poor settings.<ref>Hans [[Lofgren]], The Politics of the Pharmaceutical Industry and Access to Medicine, 2012, p. 58-59</ref> These innovations have greatly expanded access to medicine and increased drug safety by ensuring proper dosages are taken. He is also highly regarded for his role in expanding the production of bulk drugs and "active pharmaceutical ingredients" (APIs, the active chemical components in medicines) in India.<ref>Hans Lofgren, The Politics of the Pharmaceutical Industry and Access to Medicine, 2012, p. 63</ref>

Hamied has been a major benefactor to Cambridge. In 2009 the Yusuf Hamied Centre was opened at Christ's College.<ref name="hemied-centre">{{cite web|url=http://www.cam.ac.uk/news/christ%E2%80%99s-college-celebrates-the-opening-of-the-yusuf-hamied-centre|title=Christ’s officially opens Yusuf Hamied Centre|date=2009-04-20|publisher=University of Cambridge News|access-date=2009-04-20}}</ref><ref>{{cite news|url=http://www.hindu.com/thehindu/holnus/001200904220931.htm |title=The Hindu News Update Service |publisher=Hindu.com |date=2009-04-22 |access-date=2010-09-01 |location=Chennai, India}}</ref> The centre features a bronze portrait bust of Hamied by fellow Christ's College alumnus, [[Anthony Smith (sculptor)|Anthony Smith]].<ref>{{cite news|title=Cambridge salutes Mumbai boy|url=http://www.mid-day.com/articles/cambridge-salutes-mumbai-boy/128705|newspaper=[[Mid-Day]]|access-date=30 October 2016 }}</ref> The college also has a Todd-Hamied Fellow in chemistry, a post held by Professor [[Chris Abell]], FRS, from 1986 until his death in October 2020.

In 2018 he made a donation to the chemistry department at Cambridge to support the [[Yusuf Hamied 1702 Professor of Chemistry|1702 Chair of Chemistry]], the oldest professorship in the subject there, which has been renamed after him as the Yusuf Hamied 1702 Chair. There is also a Hamied Laboratory for Chemical Synthesis & Catalysis in the department, as well as a Todd-Hamied Seminar Room and Todd-Hamied Laboratory, the last two (and the Christ's fellowship) being a tribute also to [[Alexander R. Todd|Alexander, Lord Todd]], [[List of Nobel laureates|Nobel laureate]] in [[Nobel Prize in Chemistry|chemistry]], whom Hamied described as 'my [[Mentorship|mentor]] and guide over the years' since he completed his Ph.D. at Christ's College with Todd.<ref>{{cite web |url=https://www.ch.cam.ac.uk/news/giving-new-name-our-oldest-chair |title=Giving a new name to our oldest chair |website=Cambridge UniversityDepartment of Chemistry |date=2018-11-07 |access-date=2020-07-15}}</ref> Todd himself was 1702 Professor from 1944 to 1971, as well as [[List of Masters of Christ's College, Cambridge|Master of Christ's]]. In 2020 it was announced that Hamied had made a substantial donation to Cambridge University's Chemistry Department. This donation led to the foundation of the Hamied Scholars Programme, and the department has subsequently been renamed the [[Yusuf Hamied Department of Chemistry]] until 2050.<ref>{{cite web |url=https://www.ch.cam.ac.uk/news/major-gift-secures-departments-future |title=Major gift secures the Department's future |website=Cambridge UniversityDepartment of Chemistry |date=2020-12-01 |access-date=2020-12-01}}</ref>

Hamied has been the subject of in-depth profiles in ''[[The New York Times]]'', ''[[Time (magazine)|Time]]'' magazine, ''[[The Guardian]]'', ''[[Le Monde]]'', ''[[The Economist]]'', the ''[[Financial Times]]'', ''[[The Times]] (London)'', ''[[Corriere della Sera]]'', ''[[Der Spiegel]]'', ''[[Wired (magazine)|Wired]]'' and numerous other leading publications, as well as on television outlets such as ''[[ABC News]]'', the [[BBC]], [[CNN]] and [[CBS]]' ''[[60 Minutes]]''.<ref>{{cite web|url=https://www.theguardian.com/world/2003/feb/18/aids.sarahboseley13 |title= Yusuf Hamied, generic drugs boss |date=2003-02-18 |access-date=2016-09-07}}</ref>

In February 2013, Hamied announced his retirement plans from Cipla after remaining managing director of the company for 52 years.<ref name=eco13>{{cite news| title = Grand old man of Cipla Yusuf K Hamied hangs his boots|newspaper=Economic Times| url = http://articles.economictimes.indiatimes.com/2013-02-07/news/36972467_1_frank-pieters-european-respiratory-business-amar-lulla
|date=7 February 2013| access-date = 2013-11-08}}</ref> That year, ''[[Forbes]]'' magazine included him in its list of richest Indians.<ref name=Forbes/>

==Awards and recognition==
He was awarded the [[Padma Bhushan]], India's third highest civilian honour by [[Government of India]] in 2005.<ref>{{cite web|title=Padma Awards Directory (1954–2009) |publisher=[[Ministry of Home Affairs (India)|Ministry of Home Affairs]] |url=http://www.mha.nic.in/pdfs/LST-PDAWD.pdf |url-status=dead |archive-url=https://web.archive.org/web/20130510095705/http://www.mha.nic.in/pdfs/LST-PDAWD.pdf |archive-date=10 May 2013 }}</ref>

Hamied was awarded the '[[CNN-IBN Indian of the Year]]' in the category of business by [[CNN-IBN]] in 2012 "for taking on multinational pharma companies and making some of the essential drugs more affordable to the masses in the developing countries." In late 2013, he was also named one of the India's "25 Greatest Global Living Legends" by news broadcaster [[NDTV]].<ref>{{cite web | title = Dr. Yusuf Hamied message on being CNN-IBN's Indian of The Year 2012 in the business category| url = http://ibnlive.in.com/news/dr-yusuf-hamied-message-on-being-cnnibns-indian-of-the-year-2012-in-the-business-category/310908-3.html | archive-url = https://web.archive.org/web/20131218012528/http://ibnlive.in.com/news/dr-yusuf-hamied-message-on-being-cnnibns-indian-of-the-year-2012-in-the-business-category/310908-3.html | url-status = dead | archive-date = December 18, 2013 |publisher=CNN-IBN|date=Dec 17, 2012|access-date = 2013-11-08}}</ref><ref>[http://www.cipla.com/Home/Other/2013-Award.aspx] {{webarchive|url=https://web.archive.org/web/20140109033335/http://www.cipla.com/Home/Other/2013-Award.aspx|date=January 9, 2014}}</ref> He was also recently interviewed for the Creating Emerging Markets project at the [[Harvard Business School]], discussing at length his strategies to provide AIDS treatments and other drugs to help treat poor people in the developing world.<ref>{{cite web |url=http://www.hbs.edu/businesshistory/emerging-markets/pages/profile-detail.aspx?profile=yhamied |title=Interview with Yusuf Hamied |website=Creating Emerging Markets |publisher=Harvard Business School}}</ref><ref>{{YouTube|id=Sra-N-gQp-Y |title="Doing Good By Doing Business - Creating Emerging Markets"}}</ref>

==Media==
Hamied's role in the battle for mass antiretroviral treatment in Africa is portrayed in the documentary [[Fire in the Blood (2013 film)]].<ref>{{cite web|url=http://fireintheblood.com/the-contributors |title=The Contributors |publisher=Fire in the Blood |date=2013-01-20 |access-date=2016-01-26}}</ref> In its review of the film, [[India Today]] noted that "the story of Yusuf Hamied will make every Indian proud as he was the only man who decided to walk against the tide and sell drugs to save lives without focusing on profits."<ref>{{cite web|url=http://indiatoday.intoday.in/story/movie-review-fire-in-the-blood/1/314038.html |title=Movie Review: Fire in the Blood |date=2013-10-10 |access-date=2016-09-07}}</ref>

==Personal life==
Hamied married to Farida and they have no children.<ref>{{cite web|url=http://www.telegraphindia.com/1130818/jsp/7days/17242322.jsp |title=Undiplomatic departure from London |website=Telegraphindia.com |access-date=2016-01-26}}</ref> They live in [[London]] and [[Mumbai]].<ref name=Forbes />

His younger brother, M. K. Hamied, is Cipla's non-executive vice-chairman. The latter has three children, including Samina Vaziralli, who is expected to take over leadership of Cipla in the future.<ref>{{cite web|url=http://articles.economictimes.indiatimes.com/2014-11-19/news/56265412_1_mk-hamied-yusuf-k-hamied-cipla |title=Cipla chief Yusuf K Hamied grooms niece & nephew Samina Vaziralli & Kamil Hamied as genext leaders |website=Articles.economictimes.indiatimes.com |access-date=2016-01-26}}</ref>

In May 2021, ''[[Forbes]]'' estimated Hamied's net worth at [[United States dollar|US$]] 3.3 billion.<ref name=Forbes />

==References==
{{Reflist}}

{{PadmaBhushanAwardRecipients 2000–09}}
{{FRS 2019}}
{{authority control}}

{{DEFAULTSORT:Hamied, Yusuf Khwaja}}
[[Category:1936 births]]
[[Category:Living people]]
[[Category:Indian billionaires]]
[[Category:20th-century Indian chemists]]
[[Category:21st-century Indian chemists]]
[[Category:Indian businesspeople in the pharmaceutical industry]]
[[Category:Indian people of Jewish descent]]
[[Category:Indian people of Russian descent]]
[[Category:Indian Muslims]]
[[Category:Indian philanthropists]]
[[Category:Indian organic chemists]]
[[Category:Businesspeople from Mumbai]]
[[Category:Businesspeople in the pharmaceutical industry]]
[[Category:Scientists from Mumbai]]
[[Category:Indian people of Russian-Jewish descent]]
[[Category:Recipients of the Padma Bhushan in medicine]]
[[Category:Alumni of Christ's College, Cambridge]]
[[Category:Soviet emigrants to India]]
[[Category:Cathedral and John Connon School alumni]]
[[Category:Fellows of the Indian National Science Academy]]
[[Category:Cipla]]

Yusuf Hamied - Revision history

>Kailash29792: /* Career */clean up